| Staphylococcus aureus infection |
2.46 |
0.00e+0 |
72/95 (75.79%) |
CFH;DEFB1;C1QB;...
|
| Systemic lupus erythematosus |
2.26 |
0.00e+0 |
45/135 (33.33%) |
C1QB;C1R;HLA-DPB1;...
|
| Complement and coagulation cascades |
2.18 |
0.00e+0 |
76/85 (89.41%) |
CLU;CFH;CD59;...
|
| Allograft rejection |
2.12 |
0.00e+0 |
32/38 (84.21%) |
HLA-DPB1;HLA-DPA1;HLA-DQB1;...
|
| Viral protein interaction with cytokine and cytokine re... |
2.11 |
0.00e+0 |
84/100 (84%) |
CXCL14;CXCL9;CCL19;...
|
| Retinol metabolism |
2.01 |
1.31e-3 |
41/68 (60.29%) |
ALDH1A1;UGT2B28;DHRS9;...
|
| Type I diabetes mellitus |
1.95 |
3.36e-3 |
38/43 (88.37%) |
PTPRN2;HLA-DPB1;HLA-DPA1;...
|
| Primary immunodeficiency |
1.91 |
4.91e-3 |
33/38 (86.84%) |
LCK;CD8A;TAP1;...
|
| NF-kappa B signaling pathway |
1.89 |
4.36e-3 |
90/104 (86.54%) |
TLR4;CD14;CCL19;...
|
| Asthma |
1.87 |
3.92e-3 |
25/31 (80.65%) |
HLA-DPB1;HLA-DPA1;HLA-DQB1;...
|
| Antigen processing and presentation |
1.81 |
8.56e-3 |
60/78 (76.92%) |
HLA-DPB1;HLA-DPA1;CD8A;...
|
| Th1 and Th2 cell differentiation |
1.78 |
1.37e-2 |
80/92 (86.96%) |
HLA-DPB1;LCK;HLA-DPA1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.78 |
1.33e-2 |
49/77 (63.64%) |
CBR3;UGT2B28;GSTA4;...
|
| Autoimmune thyroid disease |
1.76 |
1.29e-2 |
46/53 (86.79%) |
HLA-DPB1;HLA-DPA1;HLA-DQB1;...
|
| Pyrimidine metabolism |
1.76 |
1.26e-2 |
40/56 (71.43%) |
NT5E;CDA;NME3;...
|
| Phagosome |
1.72 |
1.62e-2 |
118/152 (77.63%) |
TLR4;CD14;CYBB;...
|
| Leishmaniasis |
1.71 |
2.03e-2 |
67/77 (87.01%) |
TLR4;CYBB;HLA-DPB1;...
|
| Pentose and glucuronate interconversions |
1.68 |
2.49e-2 |
17/34 (50%) |
UGT2B28;AKR1B10;UGT2B15;...
|
| Cytokine-cytokine receptor interaction |
1.68 |
2.35e-2 |
246/295 (83.39%) |
CXCL14;CXCL9;CCL19;...
|
| Intestinal immune network for IgA production |
1.68 |
2.32e-2 |
38/48 (79.17%) |
HLA-DPB1;HLA-DPA1;HLA-DQB1;...
|
| Cell adhesion molecules |
1.67 |
2.58e-2 |
118/148 (79.73%) |
VCAM1;HLA-DPB1;CD2;...
|
| Rheumatoid arthritis |
1.66 |
2.64e-2 |
78/93 (83.87%) |
TLR4;HLA-DPB1;LTB;...
|
| Graft-versus-host disease |
1.64 |
3.04e-2 |
32/42 (76.19%) |
HLA-DPB1;HLA-DPA1;HLA-DQB1;...
|
| Hematopoietic cell lineage |
1.63 |
3.07e-2 |
90/99 (90.91%) |
CD59;CD14;IL1R2;...
|
| Steroid hormone biosynthesis |
1.62 |
3.42e-2 |
43/61 (70.49%) |
UGT2B28;UGT2B15;HSD17B2;...
|
| Pertussis |
1.62 |
3.38e-2 |
64/76 (84.21%) |
TLR4;CALML5;CD14;...
|
| Proteasome |
1.60 |
3.66e-2 |
44/46 (95.65%) |
PSMB8;PSMB9;PSME1;...
|
| Inflammatory bowel disease |
1.60 |
3.62e-2 |
58/65 (89.23%) |
TLR4;HLA-DPB1;TLR2;...
|
| Ascorbate and aldarate metabolism |
1.59 |
3.76e-2 |
15/30 (50%) |
UGT2B28;UGT2B15;ALDH2;...
|
| Relaxin signaling pathway |
-1.78 |
3.25e-2 |
114/129 (88.37%) |
ADCY6;ADCY2;COL4A4;...
|
| Central carbon metabolism in cancer |
-1.80 |
3.66e-2 |
67/70 (95.71%) |
PGAM1;PFKP;MAP2K2;...
|
| GABAergic synapse |
-1.81 |
3.96e-2 |
76/89 (85.39%) |
PLCL1;GABRD;ADCY6;...
|
| Glycine, serine and threonine metabolism |
-1.82 |
4.06e-2 |
31/40 (77.5%) |
CBS;PGAM1;PSAT1;...
|
| Alanine, aspartate and glutamate metabolism |
-1.85 |
4.88e-2 |
27/37 (72.97%) |
GFPT1;GOT1;ABAT;...
|